
SI-BONE Inc (SIBN) Stock Forecast & Price Target
SI-BONE Inc (SIBN) Analyst Ratings
Bulls say
SI-BONE is poised for continued success with strong performance in the past quarter, a positive outlook for the future with expected growth and a new product launch, and a successful partnership with SNN that will increase revenue. Although there are potential risks, SIBN is rated as a Buy and has potential for continued growth and profitability, making it an attractive investment opportunity.
Bears say
SI-BONE is a medical device company with a negative outlook due to potential multiple compression in the sector, static GMs, and limited EBITDA growth. Additionally, materiality is an important factor in evaluating ESG performance, which can vary between sectors and change over time. The launch of INTRA Ti may provide some upside potential in terms of increased procedural volumes, but it is unclear whether this will be enough to offset the overall negative outlook on the company's financials.
This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.
SI-BONE Inc (SIBN) Analyst Forecast & Price Prediction
Start investing in SI-BONE Inc (SIBN)
Order type
Buy in
Order amount
Est. shares
0 shares